INVITRO METABOLISM OF 3-(1-HYDROXY-2-PIPERIDINOETHYL)-5-PHENYLISOXAZOLE CITRATE (31252-S) WITH RABBIT LIVER HOMOGENATE

被引：0
|
作者：
HASHIMOTO, SI [1 ]
SHIZU, M [1 ]
TAKAHASHI, S [1 ]
机构：
[1] SHIONOGI & CO LTD, SHIONOGI RES LAB, FUKUSHIMA KU, OSAKA 553, JAPAN
来源：
CHEMICAL & PHARMACEUTICAL BULLETIN | 1976年 / 24卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：1757 / 1764
页数：8
相关论文
共 41 条
  • [11] INVITRO METABOLISM OF ACNU, 3-[(4-AMINO-2-METHYL-5-PYRIMIDINYL)METHYL]-1-(2-CHLOROETHYL)-1-NITROSOUREA HYDROCHLORIDE, A WATER-SOLUBLE ANTITUMOR NITROSOUREA
    NISHIGAKI, T
    NAKAMURA, KI
    TANAKA, M
    JOURNAL OF PHARMACOBIO-DYNAMICS, 1985, 8 (06): : 409 - 416
  • [12] SEMISYNTHETIC BETA-LACTAM ANTIBIOTICS .5. METABOLISM INVITRO OF 6-[(R)-2-[3-(3,4-DIHYDROXYBENZOYL)-3-(3-HYDROXYPROPYL)-1-UREIDO]-2-PHENYLACETAMIDO]PENICILLANIC ACID (AO-1100) AND SURVEYS ON THE METABOLITES
    OHI, N
    OHSAWA, Y
    NEHASHI, T
    AOKI, B
    OKAZAKI, A
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1987, 107 (10): : 814 - 818
  • [13] 6-[(2S,3R)-3-(2,4-Difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl]-5-fluoropyrimidine-4-carbaldehyde
    Sousa, Joana L. C.
    Albuquerque, Helio M. T.
    Silva, Artur M. S.
    MOLBANK, 2023, 2023 (01)
  • [14] Novel synthesis of 1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[4-(1-hydroxy-1-methyl-ethyl)-furan-2-sulfonyl]urea, an anti-inflammatory agent
    Urban, FJ
    Jasys, VJ
    Raggon, JW
    Buzon, RA
    Hill, PD
    Eggler, JF
    Weaver, JD
    SYNTHETIC COMMUNICATIONS, 2003, 33 (12) : 2029 - 2043
  • [15] PHARMACOKINETICS AND METABOLISM OF 7-[3-(HYDROXY-4-PHENYL-1-PENTENYL)-7-OXABICYCLO [2.2.1]-HEPT-2-YL]-5-HEPTENOIC ACID (SQ), A THROMBOXANE A2 RECEPTOR ANTAGONIST
    FRIEDHOFF, LT
    KRIPALANI, KJ
    WACLAWSKI, AP
    WILLARD, DA
    DEAN, AV
    MITROKA, JG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (02) : 204 - 204
  • [16] Crystal structure of (E)-3-(2-(2-hydroxy-4-methoxystyryl)-3,3-dimethyl-3H-indol-1-ium-1-yl)propane-1-sulfonate monohydrate, C22H25NO5S•H2O
    Yu, Qing
    Zhang, Qi-Long
    Xu, Hong
    Huang, Ya-Li
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2020, 235 (03): : 615 - 616
  • [17] Pharmacokinetic-Pharmacodynamic and Response Sensitization Modeling of the Intraocular Pressure-Lowering Effect of the EP4 Agonist 5-{3-[(2S)-2-{(3R)-3-hydroxy-4-[3-(trifluoromethyl)phenyl]butyl}-5-oxopyrrolidin-1-yl]propyl}thiophene-2-carboxylate (PF-04475270)
    Luu, Kenneth T.
    Zhang, Eric Y.
    Prasanna, Ganesh
    Xiang, Cathie
    Anderson, Scott
    Fortner, Jay
    Vicini, Paolo
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 331 (02): : 627 - 635
  • [18] 2-({3-[(2R,4S,5R)-4-Hydroxy-5-hydroxymethyl-2,3,4,5-tetrahydrofuran-2-yl]-5-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-1-yl}methyl)isoindoline-1,3-dione
    Bartholomae, Mark Daniel
    Ouellette, Wayne
    Zubieta, Jon
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2009, 65 : O432 - U3106
  • [19] Synthesis and Crystal Structure Characterization of (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one
    Wu, Chao
    Guo, Yan-Jun
    Zhang, Xiao-Long
    Xia, Ai-Bao
    MOLECULAR CRYSTALS AND LIQUID CRYSTALS, 2015, 607 (01) : 215 - 222
  • [20] PRETREATMENT WITH TOPICAL 0.1-PERCENT (S)-1-(3-HYDROXY-2-PHOSPHONYLMETHOXYPROPYL)CYTOSINE INHIBITS ADENOVIRUS TYPE-5 REPLICATION IN THE NEW-ZEALAND RABBIT OCULAR MODEL
    GORDON, YJ
    ROMANOWSKI, E
    ARAULLOCRUZ, T
    DECLERCQ, E
    CORNEA, 1992, 11 (06) : 529 - 533
12345